相关实验视频
Updated: Sep 20, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.6K
SARS-CoV-2 与多发性硬化症中大脑体积损失有关
Tomas Uher1, Dominika Stastna1, Ingrid Menkyova1,2
1Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia.
Annals of clinical and translational neurology
|May 30, 2025
概括
在多发性硬化症 (pwMS) 患者中,SARS-CoV-2 感染增加了大脑和脊髓组织损失,特别是在40岁以上的患者中. 这项研究强调了COVID-19在pwMS中潜在的长期神经效应.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 神经免疫学 神经免疫学
背景情况:
- SARS-CoV-2感染对多发性硬化症 (pwMS) 患者的神经影响尚不清楚.
- 研究SARS-CoV-2后大脑和脊髓病理学的变化对于管理pwMS至关重要.
研究的目的:
- 评估SARS-CoV-2感染对脑病变活动和pwMS体积的影响.
- 在pWMS中评估SARS-CoV-2感染后脊髓体积的变化.
主要方法:
- 177名已确认感染SARS-CoV-2的pwMS接受了MRI扫描.
- 分析的重点是使用混合效应模型的脑损伤负载和脑/脊髓体积.
- 患者在临床上稳定,没有疾病活性或最近的治疗变化.
主要成果:
- 感染SARS-CoV-2并没有改变脑病变的数量或体积.
- 观察到大量的全脑,灰质和皮质灰质体积损失.
- 在40岁以上的pwMS患者中发生了心室扩大;在严重的感染中观察到宫带面积减少.
结论:
- 在临床稳定的pWMS中,SARS-CoV-2感染与增加的神经元组织损失有关.
- 年龄会影响SARS-CoV-2后大脑体积变化的程度.
- SARS-CoV-2 感染的严重程度与脊髓体积减少有关.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Biological Causes of Schizophrenia
156
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
156
Brain Imaging
323
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
323

